Interleukin-10 gene polymorphisms in recurrent aphthous stomatitis.

نویسندگان

  • Shamsolmoulouk Najafi
  • Isaac Firooze Moqadam
  • Mahsa Mohammadzadeh
  • Alireza Zare Bidoki
  • Hila Yousefi
  • Elham Farhadi
  • Arghavan Tonekaboni
  • Ghasem Meighani
  • Ali Akbar Amirzargar
  • Nima Rezaei
چکیده

Recurrent aphthous stomatitis (RAS) is a common oral inflammatory disease with unknown etiology in which the immune system seems to have a role in oral tolerance. Interleukin (IL)-10 is a cytokine synthesis inhibitory factor. Single nucleotide polymorphisms (SNPs) of IL10 gene could alter this cytokine production. The aim of this study was to investigate frequencies of IL10 alleles and genotypes in a group of individuals with RAS. Genomic DNA of 60 Iranian patients with RAS were typed for IL10 gene (C/A -1082, C/T -819, and C/A -592), using PCR-SSP method. Frequency of each allele and genotype was compared to control group. A significantly higher frequencies of the T allele at position -819 (p=0.006) and the A allele at position of -592 (p<0.001) were found in the patients with RAS group, when compared to the controls. IL10 GA genotype at position -1082 (p=0.007), CA genotype at position -592 (p=0.001), and CT genotype at position -819 (p=0.001) were significantly higher in the RAS patients. The results of this study suggest that certain SNPs of IL10 gene have association with predisposition of individuals to RAS. However, further multicenter studies should be conducted to confirm the results of this study.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Salivary interleukin 2 levels in patients with recurrent aphthous stomatitis during active ulcerative and healing period

Background and Aim: Recurrent aphthous stomatitis(RAS) is one of the most common oral mucosal injuries. Various studies have shown Contradictory and varied results about inflammatory cytokines and the biological dimensions related to this complication.This study aimed to compare salivary interleukin-2 levels in patients with recurrent aphthous stomatitis (in the active ulcerative and healing pe...

متن کامل

Comparison of serum interleukin-8 levels in patients with recurrent aphthous stomatitis and healthy individuals

Comparison of serum interleukin-8 levels in patients with recurrent aphthous stomatitis and healthy individuals Dr. HR. Abdolsamadi* - Dr. Sh. Kasraie** * Assistant Professor of Oral Medicine Dept., Faculty of Dentistry, Hamadan University of Medical Sciences. ** Assistant Professor of Operative Dentistry Dept., Faculty of Dentistry, Hamadan University of Medical Sciences. Background and Aim: R...

متن کامل

Recurrent aphthous stomatitis: genetic aspects of etiology

Recurrent aphthous stomatitis (RAS; recurrent aphthous ulcers - RAU; canker sores) is a chronic inflammatory, ulcerative condition of the oral mucosa. Its prevalence in the general population ranges between 5% and 20%, depending on the method and group studied. The etiopathogenesis of the disease is considered to be multifactorial, but remains still not fully understood. In patients with RAS, a...

متن کامل

A comparison between therapeutic effect of topical Sucralfate and topical Tetracycline mouthwash suspension in recurrent Aphthous Stomatitis

Background: The current treatments of recurrent aphthous stomatitis are not very effective and are not justified for long term using due to their potential side effects. Objective: To compare the efficacy of topical sucralfate mouthwash with topical tetracycline mouthwash in recurrent aphthous stomatitis. Patients and Methods: In a randomized matched clinical trial, 60 patients with recur...

متن کامل

Apremilast for treatment of recalcitrant aphthous stomatitis

IL: interleukin RAS: recurrent aphthous stomatitis OBSERVATION Recurrent aphthous stomatitis (RAS) is a common cause of recurrent oral ulcers, which often leads to significant impairment of a patient’s quality of life. The underlying pathogenic mechanism remains unclear, and no treatment modality is uniformly effective. In this report, we describe the use of apremilast, an oral phosphodiesteras...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Immunological investigations

دوره 43 4  شماره 

صفحات  -

تاریخ انتشار 2014